Longeveron LGVN
NASDAQ LGVN
$2.59 -0.10 (-3.72%)
At close: Oct 1, 2026 · 4:00 PM EDT

Longeveron (LGVN) Current Debt (2020)

Updated

Longeveron's Current Debt came in at -$38,000 for FY2021, compared with -$25,000 in FY2020.

Analysis

Longeveron (LGVN) Current Debt (2020) Analysis & Trends

  • Per Business Quant, earlier years put Current Debt at -$25,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 37.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Longeveron 8.14 Mn -31.66 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -83,000.00
API Access

Longeveron Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=LGVN&period=max&api_key=YOUR_API_KEY